Zou, Zhen
Yan, Yiwu
Shu, Yuelong
Gao, Rongbao
Sun, Yang
Li, Xiao
Ju, Xiangwu
Liang, Zhu
Liu, Qiang
Zhao, Yan
Guo, Feng
Bai, Tian
Han, Zongsheng
Zhu, Jindong
Zhou, Huandi
Huang, Fengming
Li, Chang
Lu, Huijun
Li, Ning
Li, Dangsheng
Jin, Ningyi
Penninger, Josef M.
Jiang, Chengyu
Article History
Received: 4 September 2013
Accepted: 7 March 2014
First Online: 6 May 2014
Competing interests
: J.M.P. holds shares in Apeiron Biologics which together with GSK are developing recombinant human ACE2 for acute lung injury patients. The remaining authors have no competing financial interests to declare.
Free to read: This content has been made available to all.